• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand

    TriMed Closes Out FDA Warning Letter

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Tyber Medical Opens $8M Office and Manufacturing Facility
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    TriMed Closes Out FDA Warning Letter

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

    3D-Printed Graftless Bone Transplants Go to Clinical Trials
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    NN Life Sciences

    ARCH Medical Solutions

    Atlas Vac Machine

    Tegra Medical

    Oberg Medical
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Breaking News

    Alphatec Appoints Executive VP of Strategic Marketing and Product Development

    Company also names area vice president of sales, U.S. Central region.

    Related CONTENT
    • Alphatec Holdings Appoints Board Chairman, Welcomes New CEO
    • Alphatec Spine Replaces Resigning Board Member
    • Alphatec’s Arsenal Deformity Adolescent Scoliosis System Launched in Limited U.S. Markets
    • Alphatec Spine Appoints Chief Financial Officer
    • Alphatec Spine Launches Battalion Lateral System with Squadron Retractor
    Alphatec Holdings Inc. 03.24.17
    Alphatec Holdings Inc., parent company of Alphatec Spine Inc., a provider of spinal fusion technologies, has added two new executives with proven track records in the spine industry, naming Brian Snider as executive vice president of strategic marketing and product development, and Chris Ryan as area vice president of sales in the U.S. Central region. Drawing on their commercial spine experience, Snider and Ryan will focus on building brand awareness with surgeon customers and driving market demand for Alphatec’s differentiated product solutions. 
     
    “I am pleased to welcome Brian to the Alphatec Senior Leadership Team,” said Terry Rich, Alphatec Spine’s CEO. “Brian’s arrival completes our efforts over the past few months to restructure Alphatec leadership by adding individuals with significant spine and orthopedic experience. Brian brings a track record of building strong surgeon relationships, product innovation, and commercialization, having brought to market over 30 innovative spine products and procedures.  We look forward to leveraging his energy and expertise, as we launch our new products, including Battalion Lateral and Arsenal Deformity, deepen our engagement with surgeons, and build our brand. I look forward to partnering with Brian and believe his contributions will help take Alphatec to the next level of innovation and growth.”
     
    As Alphatec’s executive vice president of strategic marketing and product development, Snider will lead all aspects of the Company’s go-to-market strategy, including product development, marketing, brand awareness and driving market adoption.
     
    Snider has spent the past 11 years focused on marketing, brand and product development, and global product management in the spine and medical device industries. Prior to joining Alphatec Spine, Snider spent nine years at NuVasive Inc., where he most recently served as the business lead of thoracolumbar anterior, and had substantial responsibility over the anterior column business, including XLIF and anterior column realignment. Before NuVasive, Snider held marketing leadership roles at Alveolus Inc., a medical device company focused on interventional stent technologies.  He started his career at KPMG consulting in various business units, including life sciences.
     
    Snider has an M.B.A. from the Fuqua School of Business at Duke University and a bachelor’s degree in business administration from The George Washington University. 

    As Alphatec’s area vice president of sales, Central, Ryan will be responsible for expanding the company’s presence in the Central United States, including building dedicated sales agent  relationships, targeting new customer and market opportunities, as well as providing service and support for existing surgeon customers. 
     
    “I’m excited to bring Chris onboard as the first of our new regional area sales vice presidents,” said Rich. “Given the recent launch of our three new products—Arsenal Deformity, Battalion Lateral and XYcor Expandable Interbody—this is a perfect time for Chris to join the Alphatec team. Chris brings a combination of high-performing sales leadership and distribution channel transformation experience that will be crucial to leading our sales agent relationships and accelerating our growth. His reputation for high integrity, his deep understanding of the spine industry and his proven ability to drive significant revenue will make him an asset to our organization.”
     
    Ryan brings more than 20 years of progressive spine sales leadership experience to Alphatec. Prior to joining Alphatec, Ryan held multiple sales leadership roles over a six-year period with Zimmer Biomet Spine, including as its vice president of U.S. sales and a member of the Zimmer Spine leadership team. Under Ryan's leadership, Zimmer’s U.S. Spine Sales channel underwent a substantial, strategic change in distribution, yielding significant annual revenue growth. Before Zimmer, Ryan served in a number of leadership capacities during his 14-year career at Medtronic plc, including regional vice president of Medtronic's Spinal and Biologics business unit, responsible for the company’s Central region.  
     
    Ryan has a bachelor of science degree in economics from Western Michigan University. 
     
    As an inducement to entering into employment with the company, the Compensation Committee of the Board of Directors approved the following inducement awards:
     
    • Snider: 75,000 restricted stock units (RSUs) and an option to purchase 75,000 shares of common stock.
    • Ryan: 25,000 restricted stock units (RSUs) and an option to purchase 25,000 shares of common stock.
     
    The RSUs will vest in equal installments annually over four years on each of the first four anniversaries of the first date of employment, assuming in each case the employee remains continuously employed by Alphatec as of such vesting date. In addition, the RSUs will fully vest upon a change in control of Alphatec.
     
    The stock options will have an exercise price equal to the closing price per share of Alphatec’s common stock as reported by NASDAQ on the date of grant (March 20, 2017). The stock options will vest over four years, with 25 percent of the options vesting on the first anniversary of the date of grant and the remainder of the options vesting monthly over the subsequent three years, assuming in each case the employee remains continuously employed by Alphatec as of such vesting date. In addition, the options will fully vest upon a change in control of Alphatec.
     
    Alphatec Spine Inc., a wholly owned subsidiary of Alphatec Holdings Inc., designs, develops, and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Carlsbad, Calif.-based company markets products in the United States through independent sales agents and a direct sales force.
    Related Searches
    • anterior
    • arsenal deformity
    • nuvasive
    • spinal
    Suggested For You
    Alphatec Spine Launches Battalion Lateral System with Squadron Retractor Alphatec Spine Launches Battalion Lateral System with Squadron Retractor
    Alphatec Spine Appoints Chief Financial Officer Alphatec Spine Appoints Chief Financial Officer
    Alphatec’s Arsenal Deformity Adolescent Scoliosis System Launched in Limited U.S. Markets Alphatec’s Arsenal Deformity Adolescent Scoliosis System Launched in Limited U.S. Markets
    Alphatec Spine Replaces Resigning Board Member Alphatec Spine Replaces Resigning Board Member
    Alphatec Holdings Appoints Board Chairman, Welcomes New CEO Alphatec Holdings Appoints Board Chairman, Welcomes New CEO

    Related Breaking News

    • Biologics
      Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand

      Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand

      The increasing prevalence of myeloma is leading to a rise in the execution of bone marrow transplantation procedures, study concludes.
      Persistence Market Research 12.12.19

    • Extremities
      TriMed Closes Out FDA Warning Letter

      TriMed Closes Out FDA Warning Letter

      Receipt of closeout letter signals the completion of a 24-month initiative to expand and enhance quality management systems.
      Business Wire 12.11.19

    • Extremities
      FDA OKs Shoulder Innovations

      FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

      The new InSet Plus glenoids feature an angled articular surface.
      PR Newswire 12.10.19


    • Trauma/Sports
      OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

      OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

      Trauma application added to universal PhantomMSK platform; one platform with use across a variety of procedures.
      OrthoGrid 12.10.19

    • Tyber Medical Opens $8M Office and Manufacturing Facility

      Tyber Medical Opens $8M Office and Manufacturing Facility

      Creates about 30 additional jobs for Lehigh Valley's second-fastest growing company.
      PR Newswire 12.10.19

    • Extremities | Software & Quality
      FDA OKs Shoulder Surgery 3D Planner & Positioner

      FDA OKs Shoulder Surgery 3D Planner & Positioner

      Intuitive, surgeon-driven software provides 3D pre-operative planning and 3D positioners for intra-operative positioning.
      PR Newswire 12.10.19


    • Spine/Neurology
      Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

      Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review

      Patient enrollment in this U.S. study will now continue through completion of 60 total subjects.
      PR Newswire 12.10.19

    • Spine/Neurology
      InVivo Therapeutics Attains 25 Percent Enrollment in Spinal Cord Injury Study

      InVivo Therapeutics Attains 25 Percent Enrollment in Spinal Cord Injury Study

      Fourteen sites currently are open for patient enrollment.
      Business Wire 12.09.19

    • BioPrax Biofilm Disruption Device Granted FDA Breakthrough Device Designation

      BioPrax Biofilm Disruption Device Granted FDA Breakthrough Device Designation

      Product is designed to help eliminate biofilm infections on prosthetic knee implants during early intervention procedures.
      PR Newswire 12.09.19


    • Spine/Neurology
      Orthofix Appoints New Spine Business Leader

      Orthofix Appoints New Spine Business Leader

      Kevin Kenny was previously VP of U.S. sales for Spine and Biologics at Medtronic.
      Business Wire 12.05.19

    • Packaging & Sterilization
      Viant to Halt EtO Sterilization at Michigan Plant by End of Year

      Viant to Halt EtO Sterilization at Michigan Plant by End of Year

      EGLE had been investigating over the past year and issued Viant several violations for inadequate capture and control of ethylene oxide emissions.
      Michigan Department of Environment, Great Lakes, and Energy (EGLE) 12.04.19

    • Spine/Neurology
      Synaptive Medical

      Synaptive Medical's Modus V Expands Into Spine Market

      Modus V’s robotic arm moves automatically based on the positions of tracked surgical instruments.
      Business Wire 12.04.19

    • 3-D Printing/Additive Mfg. | Biologics | Materials
      3D-Printed Graftless Bone Transplants Go to Clinical Trials

      3D-Printed Graftless Bone Transplants Go to Clinical Trials

      ADAM is piloting the use of ceramics and polymer in 3D-printed bone implants, able to be produced at commodity prices.
      PR Newswire 12.04.19

    • Extremities
      CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

      CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

      The add-on acquisition furthers CrossRoads' strategy to build a market-leading company in the high-growth orthopedic extremities sector.
      PR Newswire 12.04.19

    • Spine/Neurology
      Micro Spine Implant Could Restore Standing and Walking

      Micro Spine Implant Could Restore Standing and Walking

      Hair-like electrical wires send electrical signals to trigger networks that already know how to do the hard work.
      University of Alberta Faculty of Medicine & Dentistry 12.03.19


    Breaking News
    • Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    • TriMed Closes Out FDA Warning Letter
    • FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    • OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    • Tyber Medical Opens $8M Office and Manufacturing Facility
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MedStar Health and Cleveland Clinic Innovations Awarded Grant
    3M to Sell Drug Delivery Business for $650M
    First U.S. Patient Implanted With Axonics' Sacral Neuromodulation System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Arctoris Opens Oxford R&D Facility
    Almac Group, Exostar Collaborate on IRT Experience
    Northwest Biotherapeutics Expands Management Team
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Treasuring Textured Hair
    Pacifica 'Drops' Skin Care Into Ingestible
    Skinnygirl Expands Into Supplements
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Worldwide Large Format Printer Shipments Down Slightly in 3Q 2019: IDC
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.